Filing Flows › TherapeuticsMD (TXMD) › Q1 2026 › vs Q1 2025
TherapeuticsMD (TXMD) Q1 2026 vs Q1 2025 (year over year)
TherapeuticsMD's revenue rose $331K (+84%) from $393K in Q1 2025 to $724K in Q1 2026.
TherapeuticsMD, Q1 2026: revenue $724K (+84% year over year), operating margin -99.9%, net earnings $95K, operating cash flow $944K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $724K | $393K | $331K | +84% |
| Other income, net | $826K | $596K | $230K | +39% |
| Costs & expenses | $1.6M | $1.7M | −$124K | -7% |
| Operating costs | $1.4M | $1.7M | −$227K | -14% |
| Income tax | $8K | −$32K | $40K | — |
| Net earnings | $95K | −$653K | $748K | — |
| Other operating costs | $94K | $593K | −$499K | -84% |
| Operating cash sources | $944K | $699K | $245K | +35% |
| Depreciation & amortization | $94K | $95K | −$1K | -1% |
| Share-based compensation | $2K | $23K | −$21K | -91% |
| Working capital & other | $753K | $1.2M | −$481K | -39% |
| Operating cash flow | $944K | $699K | $245K | +35% |
Questions
How much did TherapeuticsMD's revenue grow year over year in Q1 2026?
TherapeuticsMD's revenue rose $331K (+84%) from $393K in Q1 2025 to $724K in Q1 2026.